(Q45861589)

17 December 2017

title

Tissue-selective expression of dominant-negative proteins for the regulation of vascular smooth muscle cell proliferation (English)

1 reference

17 December 2017

author name string

Schmitt JF

1

1 reference

17 December 2017

Keogh MC

2

1 reference

17 December 2017

Dennehy U

3

1 reference

17 December 2017

Chen D

4

1 reference

17 December 2017

Lupu F

5

1 reference

17 December 2017

Weston K

6

1 reference

17 December 2017

Taylor D

7

1 reference

17 December 2017

Kakkar VV

8

1 reference

17 December 2017

Lemoine NR

9

1 reference

17 December 2017

publication date

1 June 1999

1 reference

17 December 2017

published in

Gene Therapy

1 reference

17 December 2017

volume

6

1 reference

17 December 2017

issue

6

1 reference

17 December 2017

page(s)

1184-1191

1 reference

17 December 2017

Long-term follow-up after percutaneous transluminal coronary angioplasty in patients with single-vessel disease

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300927

The restenosis paradigm revisited: an alternative proposal for cellular mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300927

Induction of cell cycle-dependent genes during cell cycle progression of arterial smooth muscle cells in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300927

A dominant interfering Myb mutant causes apoptosis in T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300927

Inhibition of c-myc expression induces apoptosis of WEHI 231 murine B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300927

Resistance to apoptosis in CTLL-2 cells constitutively expressing c-Myb is associated with induction of BCL-2 expression and Myb-dependent regulation of bcl-2 promoter activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300927

Inhibition of vascular smooth muscle cell proliferation in vitro and in vivo by c-myc antisense oligodeoxynucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300927

Inhibitory effects of antisense oligodeoxynucleotides targeting c-myc mRNA on smooth muscle cell proliferation and migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300927

Antiproliferative effects of a c-myc antisense oligonucleotide on human arterial smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300927

Downregulation of c-myc expression by antisense oligonucleotides inhibits proliferation of human smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300927

Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300927

The effect of oligonucleotides to c-myb on vascular smooth muscle cell proliferation and neointima formation after porcine coronary angioplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300927

The antiproliferative activity of c-myb and c-myc antisense oligonucleotides in smooth muscle cells is caused by a nonantisense mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300927

Depletion of c-myc with specific antisense sequences reverses the transformed phenotype in ras oncogene-transformed NIH 3T3 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300927

A human T lymphotropic virus type I (HTLV-I) long terminal repeat-directed antisense c-myc construct with an Epstein-Barr virus replicon vector inhibits cell growth in a HTLV-I-transformed human T cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300927

Cytostatic gene therapy for vascular proliferative disorders with a constitutively active form of the retinoblastoma gene product

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300927

Dominant interfering alleles define a role for c-Myb in T-cell development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300927

c-Myb-dependent cell cycle progression and Ca2+ storage in cultured vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300927

Myc-Max-Mad: a transcription factor network controlling cell cycle progression, differentiation and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300927

Oncogenic activity of the c-Myc protein requires dimerization with Max.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300927

Design of a muscle cell-specific expression vector utilising human vascular smooth muscle alpha-actin regulatory elements

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300927

High efficiency reporter gene transfection of vascular tissue in vitro and in vivo using a cationic lipid-DNA complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300927

S26 ribosomal protein RNA: an invariant control for gene regulation experiments in eucaryotic cells and tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300927

A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300927

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300927

7 January 2021

Remodeling rather than neointimal formation explains luminal narrowing after deep vessel wall injury: insights from a porcine coronary (re)stenosis model

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300927

7 January 2021

Deregulated expression of the c-myc oncogene abolishes inhibition of proliferation of rat vascular smooth muscle cells by serum reduction, interferon-gamma, heparin, and cyclic nucleotide analogues and induces apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300927

7 January 2021

Transcatheter delivery of c-myc antisense oligomers reduces neointimal formation in a porcine model of coronary artery balloon injury

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300927

7 January 2021

Effects of antisense c-myb oligonucleotides on vascular smooth muscle cell proliferation and response to vessel wall injury

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300927

7 January 2021

Inhibition of cellular ras prevents smooth muscle cell proliferation after vascular injury in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300927

7 January 2021

Adenovirus-mediated transfer of a dominant-negative H-ras suppresses neointimal formation in balloon-injured arteries in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300927

7 January 2021

Active repression of transcription by the engrailed homeodomain protein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300927

7 January 2021

Myc family oncoproteins function through a common pathway to transform normal cells in culture: cross-interference by Max and trans-acting dominant mutants

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300927

7 January 2021

Antagonism to estradiol in the mouse: reduced entry of receptors complexed with 4-hydroxytamoxifen into a Mg2+-soluble chromatin fraction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300927

7 January 2021

The c-Myc protein induces cell cycle progression and apoptosis through dimerization with Max.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300927

7 January 2021

APOPTOSIS: A Myc-Induced Apoptosis Pathway Surfaces

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300927

7 January 2021

Apoptosis in human atherosclerosis and restenosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300927

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3300927

1 reference

17 December 2017

Dimensions Publication ID

1051774634

0 references

1 reference

17 December 2017